JP2006525315A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525315A5
JP2006525315A5 JP2006507485A JP2006507485A JP2006525315A5 JP 2006525315 A5 JP2006525315 A5 JP 2006525315A5 JP 2006507485 A JP2006507485 A JP 2006507485A JP 2006507485 A JP2006507485 A JP 2006507485A JP 2006525315 A5 JP2006525315 A5 JP 2006525315A5
Authority
JP
Japan
Prior art keywords
dosage form
active agent
agent component
barrier
transdermal dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006507485A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525315A (ja
Filing date
Publication date
Priority claimed from US10/744,966 external-priority patent/US20040219195A1/en
Application filed filed Critical
Publication of JP2006525315A publication Critical patent/JP2006525315A/ja
Publication of JP2006525315A5 publication Critical patent/JP2006525315A5/ja
Pending legal-status Critical Current

Links

JP2006507485A 2003-04-30 2004-03-23 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形 Pending JP2006525315A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US46724303P 2003-04-30 2003-04-30
US10/744,966 US20040219195A1 (en) 2003-04-30 2003-12-23 Abuse-resistant transdermal dosage form
PCT/US2004/008856 WO2004098568A2 (en) 2003-04-30 2004-03-23 Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012064165A Division JP2012140453A (ja) 2003-04-30 2012-03-21 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形

Publications (2)

Publication Number Publication Date
JP2006525315A JP2006525315A (ja) 2006-11-09
JP2006525315A5 true JP2006525315A5 (https=) 2007-05-10

Family

ID=33313652

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006507485A Pending JP2006525315A (ja) 2003-04-30 2004-03-23 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形
JP2012064165A Pending JP2012140453A (ja) 2003-04-30 2012-03-21 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012064165A Pending JP2012140453A (ja) 2003-04-30 2012-03-21 活性薬剤構成要素および活性薬剤層の遠位に逆作用薬剤構成要素を含んでなる不正使用防止機能付き経皮的剤形

Country Status (9)

Country Link
US (2) US20040219195A1 (https=)
EP (1) EP1651196B1 (https=)
JP (2) JP2006525315A (https=)
AT (1) ATE423551T1 (https=)
AU (2) AU2004237579A1 (https=)
CA (1) CA2523709A1 (https=)
DE (1) DE602004019653D1 (https=)
ES (1) ES2322154T3 (https=)
WO (1) WO2004098568A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
CN101232875B (zh) 2005-06-10 2014-06-25 3M创新有限公司 处理粘合层叠片片段的方法
BRPI0619806A2 (pt) * 2005-12-13 2011-10-18 Biodelivery Sciences Int Inc dispositivo para fornecimento de fármacos transmucosal resistente ao abuso
US7740879B2 (en) * 2006-01-17 2010-06-22 Harrogate Holdings Abuse resistant transdermal drug delivery patch
DE102006025282A1 (de) 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
RU2504377C2 (ru) 2006-07-21 2014-01-20 БайоДеливери Сайенсиз Интэнэшнл, Инк. Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
WO2008073576A1 (en) * 2006-12-08 2008-06-19 Alcon, Inc. Drug delivery device
EP2259780A2 (en) 2008-02-28 2010-12-15 Syntropharma Limited Pharmaceutical composition comprising naltrexone
JP5386205B2 (ja) * 2009-03-19 2014-01-15 リンテック株式会社 経皮吸収型貼付剤
JP2013524275A (ja) * 2010-04-03 2013-06-17 ドシ，プラフル 薬剤を含む医療機器、その製造方法とその使用方法
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
WO2013148506A1 (en) * 2012-03-30 2013-10-03 3M Innovative Properties Company Urea-based and urethane-based pressure sensitive adhesive blends
US9950106B2 (en) 2012-12-05 2018-04-24 Cook Medical Technologies Llc Antimicrobial barrier device
CN115444659A (zh) * 2014-01-22 2022-12-09 4P治疗公司 滥用和误用制止透皮系统
WO2016099986A2 (en) 2014-12-18 2016-06-23 3M Innovative Properties Company Methods of handling adhesive laminate patches
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
CN107613853A (zh) 2015-01-23 2018-01-19 马尔西奥·马克·阿布雷乌 用于皮肤处理的设备和方法
CN110470607B (zh) * 2018-05-09 2021-12-07 江苏集萃智能液晶科技有限公司 一种检测混合溶液中亲水性有机溶剂含量的方法
WO2020008370A1 (en) * 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal patch

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1602344A (en) * 1924-01-09 1926-10-05 Eagle Peter Medicating compress
US2807262A (en) * 1952-12-10 1957-09-24 Robert B Lew Perforated plastic adhesive tape bandage
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4539256A (en) * 1982-09-09 1985-09-03 Minnesota Mining And Manufacturing Co. Microporous sheet material, method of making and articles made therewith
US4693776A (en) * 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4743249A (en) * 1986-02-14 1988-05-10 Ciba-Geigy Corp. Dermal and transdermal patches having a discontinuous pattern adhesive layer
DE3634016A1 (de) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg Flaechenfoermiges therapeutisches system, verfahren zu seiner herstellung und seine verwendung
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
JPH0538010Y2 (https=) * 1987-03-17 1993-09-27
DE3722775A1 (de) * 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts Transdermales therapeutisches system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5176917A (en) * 1989-03-15 1993-01-05 Lts Lohmann Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
CA2173855C (en) * 1993-10-29 2007-06-26 Mieczyslaw H. Mazurek Pressure-sensitive adhesives having microstructured surfaces
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
WO1997004835A1 (de) * 1995-07-28 1997-02-13 Novartis Ag Transdermales system
US5840327A (en) * 1995-08-21 1998-11-24 Alza Corporation Transdermal drug delivery device having enhanced adhesion
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US20020110585A1 (en) * 1999-11-30 2002-08-15 Godbey Kristin J. Patch therapeutic agent delivery device having texturized backing
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
ATE364380T1 (de) * 2001-03-16 2007-07-15 Alza Corp Transdermales pflaster zur verabreichung von fentanyl
SI2062573T1 (sl) * 2001-05-01 2012-02-29 Euro Celtique Sa Proti zlorabi odporni transdermalni sistemi, ki vsebujejo opioid
TW200404581A (en) * 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
DK1530469T3 (da) * 2002-08-20 2009-05-04 Euro Celtique Sa Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist
US20040109886A1 (en) * 2002-08-27 2004-06-10 Larry Rigby Methods and apparatus for transdermal delivery of abusable drugs with a deterrent agent
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
US7182955B2 (en) * 2003-04-30 2007-02-27 3M Innovative Properties Company Abuse-resistant transdermal dosage form
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
DE102004038179A1 (de) * 2004-08-06 2006-03-16 Daimlerchrysler Ag Verfahren zur Herstellung einer thermisch beschichteten Zylinderlauffläche mit einer Einfuhrfase

Similar Documents

Publication Publication Date Title
JP2006525315A5 (https=)
JP2006525316A5 (https=)
del Consuelo et al. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl
US11246840B2 (en) Abuse and misuse deterrent transdermal systems
TWI435737B (zh) 經皮遞送醫藥化合物的方法及其組成物
TWI454249B (zh) 用於治療或預防甲癬或足癬之壓敏膠黏劑基質藥貼裝置
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
WO2005112984A3 (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
JP2007536311A5 (https=)
JP5137286B2 (ja) フェンタニル含有口腔粘膜貼付剤
NO20061859L (no) OROS Push Stick for kontrollert tilforsel av aktive midler
AU2006216955A1 (en) Transdermal systems having control delivery system
KR101050002B1 (ko) 다층 경점막성 치료시스템
WO2004098568A3 (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
WO2011029948A3 (de) Transdermales therapeutisches system zur verabreichung von fentanyl oder einem analogstoff davon
WO2004012676A3 (en) Drug-loaded biological material chemically treated with genipin
ATE361060T1 (de) Ionenstärkenunabhängige pharmazeutische formulierung mit verzögerter freisetzung
WO2001013898A3 (en) Pharmaceutical formulations with different release times
CO5640120A2 (es) Formulacion y metodods para el tratamiento de trombocitemia
US20070248657A1 (en) Multi-compartment transdermal pain control device
JP2024543149A (ja) 経口マイクロニードルパッチ
RU2434631C2 (ru) Трансдермальная терапевтическая система для летучих и/или термолабильных веществ
WO2005079750A3 (en) Films for use as dosage forms
CR8059A (es) Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas
CN1377258A (zh) 含活性成分和/或辅助物质且可控制释出这些物质的制剂及其用途和制造